LENZ Therapeutics, Inc. (LENZ) vs Nutriband Inc. (NTRB)

LENZ Therapeutics, Inc. and Nutriband Inc. are both Biotechnology companies. LENZ Therapeutics, Inc. and Nutriband Inc. are of similar size ($117.4M and $115.2M). Nutriband Inc. has the higher net margin (−430.4% vs −586.7%) and the lower return on invested capital (−227.9% vs 0.00%). Across the 16 metrics below, LENZ Therapeutics, Inc. leads on 10 and Nutriband Inc. on 6.

Valuation

Metric LENZ NTRB Biotechnology median
P/E n/m n/m 7.88
P/S 5.73 60.12 11.47
P/B 0.56 18.26 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.69 n/m 0.74
EV/Sales (4.36) 58.11 10.73
Earnings yield (104.34%) (7.16%) (28.84%)
Free cash flow yield (93.03%) (3.74%) (23.03%)

Profitability

Metric LENZ NTRB Biotechnology median
Gross margin 93.69% 33.14% 65.16%
Operating margin (631.70%) (435.57%) 0.00%
Net margin (586.74%) (430.43%) 0.00%
Free cash flow margin (532.80%) (224.54%) 0.00%
Return on equity (59.21%) (100.79%) (57.72%)
Return on assets (55.52%) (84.56%) (49.22%)
Return on invested capital 0.00% (227.92%) 0.00%

Growth

Metric LENZ NTRB Biotechnology median
Revenue growth (TTM) — (37.25%) 5.64%
EPS growth (last fiscal year) (21.79%) (160.61%) —
Revenue growth, 5-year CAGR — 16.63% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LENZ NTRB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 13.55 4.21 4.73
Net debt to EBITDA 3.22 0.56 0.96

Dividend

Metric LENZ NTRB Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric LENZ NTRB Biotechnology median
Market cap 117.38m 115.24m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack